Method of producing non-woven protein fibers

Patent metadata

Field	Value
Publication number	US-11549198-B2
Application number	US-201816605848-A
Country	US
Kind code	B2
Filing date	Apr 17, 2018
Priority date	Apr 17, 2017
Publication date	Jan 10, 2023
Grant date	Jan 10, 2023

Abstract

The invention relates to non-woven protein fibers and to methods for forming and producing the same. In certain embodiments, the invention provides a method of processing a protein comprising dissolving a protein in a solution, optionally removing any insoluble materials from the solution, and spraying the solution under an applied pressure. In other embodiments, the protein can be derived from a range of sources, including but not limited to arthropod silks, animal keratin (e.g. hair and wool), tissue elastin, collagen, resilin, and plant protein. In certain embodiments, the methods of the invention are an alternative to electrospinning methods known in the art.

First claim

What is claimed is:

1. A method of producing non-woven protein fibers, the method comprising:
(a) dissolving a protein in an acidic solution, wherein the acidic solution comprises more than about 80% acidic component by volume;
(b) optionally removing any insoluble material from the solution; and
(c) spraying the solution under an applied pressure at a collection surface, such that the solution evaporates after being sprayed, forming protein fibers upon reaching or before reaching the collection surface;
wherein the solution is sprayed without application of an electrical potential; and
wherein at least one additional non-protein material is present in the acidic solution and is selected from the group consisting of a pharmaceutical agent, synthetic polymer, natural polymer, plasticizer, metal, metal alloy, metal oxide, metal salt, ceramic, glass, natural composite, synthetic composite, carbon material, nanoparticle, nanotube, nanofiber, nanosheet, microsphere, microfiber, and any combinations thereof.

2. The method of claim 1 , wherein the at least one additional non-protein material is at least one of the following:
(a) a metal oxide selected from the group consisting of SiO 2 , TiO 2 , CaO, Al 2 O 3 , CuO, ZnO, FeO, MnO, NiO, BaO, SrO, and Fe 2 O 3 ;
(b) a pharmaceutical agent selected from the group consisting of an antibiotic, a β-lactamase inhibitor, an anti-diabetic agent, and an anticancer agent;
(c) a synthetic polymer selected from the group consisting of poly(lactic-co-glycolic acid) (PLGA), polystyrene, polyvinylchloride, poly(styrene sulfonate), poly(acrylic acid) (PAA), poly(diallyldimethylammoniumchloride) (PDADMAC), polyglycolic (PGA) acid and polylactic acid (PLA)
(d) a natural polymer selected from the group consisting of cellulose, chitin, and starch;
(e) a carbon material selected from the group consisting of graphene, carbon nanotubes, carbon nanofibers, and fullerenes;
(f) a plasticizer selected from the group consisting of sorbitan, sorbitan anhydrides, castor oil, mono-acetylated monoglycerides, di-acetylated monoglycerides, glycerin triacetate, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, galactitol, fucitol, iditol, inositol, volemitol, isomalt, maltitol, lactitol, maltotriitol, maltotetraitol, polyglycitol, polyvinyl alcohol, propylene glycol, triethyl citrate, tributyl citrate, acetyl triethyl citrate, acetyl tributyl citrate, n-butyryl tri-n-hexyl citrate, oleic acid, steric acid, polyethylene glycols, and any combinations thereof.

3. The method of claim 2 , wherein the at least one pharmaceutical agent is selected the group consisting of rifampin, meticillin, nafcillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, aminopenicillins, ampicillin, amoxicillin, pivampicillin, hetacillin, bacampicillin, metampicillin, talampicillin, epicillin, carboxypenicillins, carbenicillin, ticarcillin, temocillin, ureidopenicillins, mezlocillin, piperacillin, β-lactamase inhibitors, clavulanic acid, sulbactam, tazobactam, insulins, biguanides, metformin, phenformin, buformin, thiazolidinediones, rosiglitazone, pioglitazone, troglitazone, doxorubicin, cyclophosphamide, amsacrine, bleomycin, capecitabine, carmustine, docetaxel, eribulin, fluorouracil, gemcitabine, hydroxycarbamide, idarubicin, temozolomide, thiotepa, tioguanine, topotecan, trabectedin, treosulfan, vinblastine, and vinorelbine.

4. The method of claim 1 , wherein the protein is derived from at least one natural source selected from the group consisting of arthropod silk, keratin, tissue elastin, collagen, resilin, reflectin, and plant proteins.

5. The method of claim 4 , wherein the protein is derived from at least one arthropod silk source selected from the group consisting of Bombyx mori silk, Samia cynthia silk, Antheraea assamensis silk, Antheraea mylitta silk, Antheraea paphia silk, Antheraea pernyi silk, Antheraea roylei silk, Antheraea yamamai silk, and spider silk.

6. The method of claim 4 , wherein the protein is derived from at least one protein source selected from the group consisting of Indian Antheraea mylitta silk (Tussah), Philosamia ricini silk (Eri), Antheraea assamensis silk (Muga), Thailand silk (Thai) and Bombyx mori mulberry silk (Mori).

7. The method of claim 4 , wherein the protein is derived from at least one plant source selected from the group consisting of corn zein, wheat gliadin, wheat gluten, barley hordein, rye secalin, sorghum kafirin, oat avenin, soy, and any combinations thereof.

8. The method of claim 1 , wherein the protein is artificial or recombinant.

9. The method of claim 1 , wherein the protein is dissolved in the acidic solution at a concentration of about 1 g/L to about 600 g/L.

10. The method of claim 1 , wherein the acidic component is selected from the group consisting of formic acid, acetic acid, hydrochloric acid, propionic acid, butyric acid, valeric acid, caproic acid, oxalic acid, lactic acid, malic acid, citric acid, benzoic acid, carbonic acid, phenol, uric acid, and any combinations thereof.

11. The method of claim 1 , wherein the acidic solution comprises a salt comprising: at least one cation selected from the group consisting of lithium, sodium, potassium, calcium, magnesium, zinc, iron, ammonium, and any combinations thereof; or at least one anion selected from the group consisting of hydroxide, gluceptate, gluconate, acetate, propionate, lactate, nitrate, chloride, bromide, fluoride, iodide, sulfate, carbonate, phosphate, and any combinations thereof.

12. The method of claim 1 , wherein the acidic solution comprises at least one salt selected from the group consisting of CaCl 2 , NaCl, KCl, and MgCl 2 .

13. The method of claim 1 , wherein the insoluble materials are removed from the solution via a method selected from the group consisting of decantation, centrifugation, and filtration.

14. The method of claim 1 , wherein the solution is sprayed using an airbrush.

15. The method of claim 1 , wherein the solution is sprayed at an applied pressure of about 5 psi to about 200 psi.

16. The method of claim 1 , further comprising drying the protein fibers.

17. The method of claim 1 , wherein the method produces protein fibers having at least one of the following:
(a) an average diameter of about 0.1 μm to about 200 μm;
(b) an average length of about 1 μm to about 10 m.

18. The method of claim 1 , wherein the method produces protein fibers that are not soluble in water.

19. A method of producing non-woven protein fibers, the method comprising:
(a) dissolving a protein in an acidic solution, wherein the protein is derived from at least one natural source selected from the group consisting of arthropod silk and plant proteins;
(b) optionally removing any insoluble material from the solution; and
(c) spraying the solution under an applied pressure at a collection surface, such that the solution evaporates after being sprayed, forming protein fibers upon reaching or before reaching the collection surface;
wherein the solution is sprayed without application of an electrical potential; and
wherein at least one additional non-protein material is present in the acidic solution and is selected from the group consisting of a pharmaceutical agent, synthetic polymer, natural polymer, plasticizer, metal, metal alloy, metal oxide, metal salt, ceramic, glass, natural composite, synthetic composite, carbon material, nanoparticle, nanotube, nanofiber, nanosheet, microsphere, microfiber, and any combinations thereof.

20. The met

Assignees

• Univ Rowan

Inventors

• Hu Xiao
• Mou Xiaoyang

Classifications

• D01D5/26

  Formation of staple fibres (by flash-spinning D01D5/11) · CPC title

• D10B2211/04

  Silk · CPC title

• B29C41/085

  by rotating the former around its axis of symmetry · CPC title

• D10B2211/06

  Collagen fibres · CPC title

• B29K2005/00

  Use of polysaccharides or derivatives as moulding material · CPC title